Question for Ohm and other biochem experts -

For treatment of mild-moderate Covid 19, do you know how Leronlimab stacks up (or would stack up) vs another monoclonal antibody called Regkirona (regdanvimab)?

I just read an article that said regdanvimab has the best results against mild-moderate Covid of any existing treatment. It's made by Celltrion, and I think they're a South Korean company. Didn't see much about SAE's, so it sounds pretty safe.

Thanks!